Real-time transcription polymerase chain reaction cycle threshold values as criteria for utilization of incidental COVID-19 positive lung donors.


Journal

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
ISSN: 1557-3117
Titre abrégé: J Heart Lung Transplant
Pays: United States
ID NLM: 9102703

Informations de publication

Date de publication:
03 2023
Historique:
received: 16 11 2022
revised: 17 12 2022
accepted: 20 12 2022
pubmed: 10 1 2023
medline: 25 2 2023
entrez: 9 1 2023
Statut: ppublish

Résumé

Shortage of organ donors is an ongoing limiting factor in lung transplantation (LT). Despite increasing prevalence of asymptomatic COVID-19 infection, positive COVID-19 testing from a potential donor remains a contraindication at many LT centers. In this report, we present the outcomes of LT utilizing an algorithm based on donor clinical presentation, and COVID-19 real-time reverse transcription polymerase chain reaction (RT-PCR) with cycle threshold (Ct) values evaluation. The Ct value threshold for organ acceptance was >35. A total of 8 COVID-positive donors were included. No donor-to-recipient transmissions of COVID-19 were observed. Short-term outcomes were comparable to those reported in pre-COVID literature. Survival-to-date is 100% with median POD of 161 days. Our findings support the safety and efficacy of utilizing our algorithm including Ct value threshold for selection of donors with incidental COVID-19 positive testing.

Identifiants

pubmed: 36624019
pii: S1053-2498(22)02272-0
doi: 10.1016/j.healun.2022.12.016
pmc: PMC9794393
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

301-304

Informations de copyright

Copyright © 2022 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.

Auteurs

Josephine Hwang (J)

Cedars-Sinai Medical Center, Los Angeles, California.

Alexander Yuen (A)

Cedars-Sinai Medical Center, Los Angeles, California.

Joshua Rhoades (J)

Cedars-Sinai Medical Center, Los Angeles, California.

Darina Barnes (D)

Cedars-Sinai Medical Center, Los Angeles, California.

Phillip Zakowski (P)

Cedars-Sinai Medical Center, Los Angeles, California.

Dominick J Megna (DJ)

Cedars-Sinai Medical Center, Los Angeles, California.

Pedro Catarino (P)

Cedars-Sinai Medical Center, Los Angeles, California.

Lorenzo Zaffiri (L)

Cedars-Sinai Medical Center, Los Angeles, California. Electronic address: lorenzo.zaffiri@cshs.org.

Reinaldo Rampolla (R)

Cedars-Sinai Medical Center, Los Angeles, California.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH